Premier Path Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.47M Buy
22,394
+3,745
+20% +$872K 0.71% 33
2025
Q4
$3.86M Buy
18,649
+1,144
+7% +$226K 0.5% 40
2025
Q3
$3.25M Buy
17,505
+2,030
+13% +$348K 0.42% 53
2025
Q2
$2.36M Sell
15,475
-2,741
-15% -$421K 0.33% 70
2025
Q1
$3.02M Buy
18,216
+2,142
+13% +$335K 0.47% 48
2024
Q4
$2.32M Buy
16,074
+4,111
+34% +$637K 0.35% 64
2024
Q3
$1.94M Buy
11,963
+1,221
+11% +$195K 0.31% 80
2024
Q2
$1.57M Sell
10,742
-3,975
-27% -$591K 0.27% 92
2024
Q1
$2.32M Sell
14,717
-557
-4% -$88.7K 0.44% 52
2023
Q4
$2.39M Buy
+15,274
New +$2.34M 0.53% 37

Other funds holding JNJ

Premier Path Wealth Partners's JNJ Position: Q1 2026 in Review

Premier Path Wealth Partners increased its Johnson & Johnson (JNJ) stake by 20% in Q1 2026, buying an estimated $872K and bringing the position to 22,394 shares worth $5.47M. The position accounts for 0.71% of the portfolio, ranked #33.

Premier Path Wealth Partners first reported a position in JNJ in Q4 2023 and has held it in 10 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Premier Path Wealth Partners held 22,394 shares of Johnson & Johnson worth $5.47M as of Q1 2026.
  • Premier Path Wealth Partners bought 3,745 Johnson & Johnson shares in Q1 2026, an estimated $872K.
  • Johnson & Johnson made up 0.71% of Premier Path Wealth Partners's portfolio in Q1 2026, its #33 holding.
  • Premier Path Wealth Partners first reported a position in Johnson & Johnson in Q4 2023 and has held it in 10 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Premier Path Wealth Partners's 13F filing for Q1 2026, filed 23 Apr 2026.